| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 203 companies in the Health Care Equipment & Supplies industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 13, 2024 | ECOR Electrocore, Inc. | Gandolfo John P | Director | Buy | 1,000 | $6.43 | $6,430.00 | +2.0% | -5.4% | -19.7% | |
| Jun 12, 2024 | EW Edwards Lifesciences Corp | Bobo Donald E Jr64 | Cvp,Strategy/ Corp Development | Sell | 5,000 | $87.54 | $437,696.50 | -9.6% | -23.5% | -13.5% | |
| Jun 12, 2024 | ISRG Intuitive Surgical Inc | Barratt Craig H48 | Director | Sell | 1,400 | $421.06 | $589,484.00 | -100% | +13.1% | +19.8% | |
| Jun 12, 2024 | OM Outset Medical, Inc. | Brottem John L.84 | General Counsel | Sell | 10,569 | $4.78 | $50,519.82 | -4.3% | -89.0% | -70.7% | |
| Jun 12, 2024 | INCY Incyte Corp | Flannelly Barry P50 | EVP &General Manager Us | Sell | 19,164 | $60.00 | $1,149,840.00 | -22.4% | +5.3% | +15.5% | |
| Jun 12, 2024 | ATEC Alphatec Holdings, Inc. | Marshall Tyson Eliot62 | General Counsel &Corp. Sec. | Sell | 50,232 | $10.88 | $546,524.16 | -17.0% | -48.4% | +5.5% | |
| Jun 12, 2024 | ZOMDF Zomedica Corp. | Klass Russell Kevin | Vice President Of Sales | Buy | 299,993 | $0.16 | $46,528.91 | +17.6% | - | - | |
| Jun 12, 2024 | WRBY Warby Parker Inc. | Miller Steven Clive64 | Chief Financial Officer | Sell | 109,210 | $16.61 | $1,813,790.22 | -24.0% | -16.2% | +35.6% | |
| Jun 11, 2024 | TMCI Treace Medical Concepts, Inc. | Treace John T.60 | Chief Executive Officer | Buy | 45,000 | $5.88 | $264,600.00 | +0.7% | -11.3% | +5.5% | |
| Jun 11, 2024 | ZOMDF Zomedica Corp. | Klass Russell Kevin | Vice President Of Sales | Buy | 700,007 | $0.15 | $105,041.05 | +31.8% | - | - | |
| Jun 11, 2024 | VERO Venus Concept Inc. | Masters Michael Willingham83 | 10% Owner | Sell | 489,948 | $1.20 | $589,868.34 | -43.5% | -49.1% | -79.1% | |
| Jun 10, 2024 | DXCM Dexcom Inc | Stern Sadie72 | EVP Chief Hr Officer | Sell | 427 | $115.05 | $49,126.95 | -0.6% | -40.2% | -27.2% | |
| Jun 10, 2024 | PODD Insulet Corp | Field Mark N | SVP &Chief Technology Officer | Sell | 2,131 | $190.43 | $405,806.33 | -12.9% | +14.1% | +55.6% | |
| Jun 10, 2024 | ISRG Intuitive Surgical Inc | Desantis Robert49 | EVP &Chief Strategy &Corp Op | Sell | 239 | $416.60 | $99,567.40 | -2.1% | +14.6% | +26.6% | |
| Jun 10, 2024 | DXCM Dexcom Inc | Sylvain Jereme M65 | EVP Chief Financial Officer | Sell | 745 | $115.05 | $85,712.85 | -0.9% | -40.2% | -27.2% | |
| Jun 10, 2024 | MMSI Merit Medical Systems Inc | Peterson Neil51 | Chief Operating Officer | Sell | 7,500 | $81.85 | $613,845.00 | -33.6% | +18.5% | +15.8% | |
| Jun 10, 2024 | SERA Sera Prognostics, Inc. | Aerts Austin77 | Chief Financial Officer | Sell | 5,415 | $8.11 | $43,915.65 | -1.7% | -9.7% | -81.6% | |
| Jun 10, 2024 | NXL Nexalin Technology, Inc. | Owens David | Chief Medical Officer | Buy | 3,000 | $0.64 | $1,920.00 | +1.1% | +22.7% | +90.2% | |
| Jun 10, 2024 | ZOMDF Zomedica Corp. | Donato Peter | Chief Financial Officer | Buy | 25,000 | $0.15 | $3,797.50 | New | - | - | |
| Jun 10, 2024 | PRCT Procept Biorobotics Corp | Shiblaq Hisham55 | EVP, Chief Comm. Officer | Sell | 26,046 | $68.24 | $1,777,498.85 | -31.8% | +11.7% | -6.5% | |
| Jun 10, 2024 | PODD Insulet Corp | Scannell Timothy J | Director | Sell | 7,000 | $190.51 | $1,333,570.00 | -16.4% | +14.1% | +55.6% | |
| Jun 10, 2024 | SERA Sera Prognostics, Inc. | Lindgardt Zhenya75 | Chief Executive Officer | Sell | 26,867 | $8.11 | $217,891.37 | -3.0% | -9.7% | -81.6% | |
| Jun 10, 2024 | RMD Resmed Inc | Sandercock Brett62 | Chief Financial Officer | Sell | 1,000 | $209.81 | $209,810.00 | -1.1% | +17.9% | +19.4% | |
| Jun 10, 2024 | BDX Becton Dickinson & Co | Spoerel Thomas J58 | SVP,Controller&Chief Acct Off | Sell | 300 | $239.31 | $71,793.00 | -13.2% | -0.5% | -25.8% | |
| Jun 10, 2024 | DXCM Dexcom Inc | Leach Jacob Steven55 | EVP Chief Operating Officer | Sell | 745 | $115.05 | $85,712.85 | -0.3% | -40.2% | -27.2% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.